Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-19

Clinical Trial Update: Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pemetrexed disodium in combination with cisplatin for patients undergoing surgery for stages I–III non-small cell lung cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • Platinol (cisplatin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19